IGF1 and Alzheimer disease: Extensive disturbances in brain insulin and insulin like growth factor 1 (IGF-1) signaling mechanisms represent early and progressive abnormalities and could account for the majority of the molecular, biochemical, and histopathological lesions in AD [5].